In March 2022 the International Cricket Council (ICC) has reported an anti-doping rule violation against the South African cricket player Zubayr Hamza after his sample tested positive for the prohibited substance Furosemide.
After notification, the Athlete gave a prompt admission, waived his right for a hearing, accepted a provisional suspension and the sanction proposed by the ICC.
The Athlete denied the intentional use of the substance and explained that by mistake he had used one of his father's heart pills instead of his own anti-allergy medciation. The round white tablet of his medication looked very similar to his father's medication and both medications were kept in the family medicine box.
Based on the evidence the ICC concludes that the anti-doping rule violation was not intentional and that the Athlete established No Significant Fault or Negligence.
Therefore the ICC decides on 17 May 2022 to impose a 9 month period of ineligibility on the Athlete, starting on the date of de provisional suspension, i.e. on 22 March 2022.
